| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thoracic Surgery, Video-Assisted | 9 | 2018 | 97 | 4.43 | Why? |
| Carcinoma, Non-Small-Cell Lung | 12 | 2019 | 896 | 2.89 | Why? |
| Lung Neoplasms | 22 | 2019 | 3228 | 2.88 | Why? |
| Adenocarcinoma | 6 | 2017 | 651 | 1.78 | Why? |
| Tracheal Neoplasms | 4 | 2018 | 16 | 1.75 | Why? |
| Pneumonectomy | 4 | 2018 | 278 | 1.40 | Why? |
| Biomarkers, Tumor | 7 | 2018 | 1314 | 1.06 | Why? |
| Anesthesia, Intravenous | 2 | 2017 | 37 | 0.86 | Why? |
| Solitary Pulmonary Nodule | 2 | 2018 | 83 | 0.79 | Why? |
| Membrane Transport Modulators | 1 | 2017 | 11 | 0.72 | Why? |
| Circulating Tumor DNA | 1 | 2018 | 46 | 0.71 | Why? |
| Chloride Channels | 1 | 2017 | 51 | 0.70 | Why? |
| Receptors, LDL | 1 | 2017 | 42 | 0.69 | Why? |
| Camptothecin | 1 | 2017 | 39 | 0.69 | Why? |
| Glucuronosyltransferase | 1 | 2017 | 24 | 0.69 | Why? |
| Lung Transplantation | 2 | 2020 | 1554 | 0.68 | Why? |
| Esophagectomy | 1 | 2017 | 76 | 0.66 | Why? |
| Stearoyl-CoA Desaturase | 1 | 2016 | 13 | 0.66 | Why? |
| Endoscopic Mucosal Resection | 1 | 2017 | 63 | 0.66 | Why? |
| One-Lung Ventilation | 1 | 2017 | 53 | 0.66 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.64 | Why? |
| Small Cell Lung Carcinoma | 1 | 2018 | 133 | 0.62 | Why? |
| Trachea | 2 | 2018 | 894 | 0.61 | Why? |
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 3 | 0.61 | Why? |
| Statistics as Topic | 1 | 2018 | 370 | 0.60 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 183 | 0.59 | Why? |
| Diaphragm | 1 | 2018 | 232 | 0.58 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 243 | 0.56 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2018 | 782 | 0.55 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2017 | 260 | 0.55 | Why? |
| Antineoplastic Agents | 4 | 2018 | 3550 | 0.53 | Why? |
| Ventilator Weaning | 1 | 2018 | 536 | 0.50 | Why? |
| SEER Program | 3 | 2017 | 146 | 0.49 | Why? |
| Bias | 1 | 2018 | 1109 | 0.49 | Why? |
| DNA Damage | 1 | 2015 | 285 | 0.48 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 451 | 0.47 | Why? |
| Esophageal Neoplasms | 1 | 2017 | 357 | 0.47 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.47 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.46 | Why? |
| Thoracic Surgical Procedures | 1 | 2017 | 504 | 0.46 | Why? |
| Propensity Score | 2 | 2017 | 2690 | 0.45 | Why? |
| Reconstructive Surgical Procedures | 2 | 2018 | 860 | 0.44 | Why? |
| Neoplasm Staging | 5 | 2018 | 1999 | 0.42 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.41 | Why? |
| Robotic Surgical Procedures | 1 | 2018 | 787 | 0.41 | Why? |
| Protein Kinase Inhibitors | 2 | 2019 | 1585 | 0.40 | Why? |
| Lymph Nodes | 1 | 2016 | 1060 | 0.40 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.38 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.37 | Why? |
| Airway Management | 1 | 2018 | 1298 | 0.35 | Why? |
| Anesthesia | 2 | 2017 | 1236 | 0.34 | Why? |
| Treatment Outcome | 12 | 2019 | 51732 | 0.32 | Why? |
| Neoplasms | 4 | 2020 | 17251 | 0.32 | Why? |
| Respiration, Artificial | 6 | 2020 | 22116 | 0.32 | Why? |
| Mutation | 4 | 2019 | 12376 | 0.28 | Why? |
| Cell Line, Tumor | 4 | 2017 | 3608 | 0.27 | Why? |
| Triage | 2 | 2021 | 7151 | 0.27 | Why? |
| Molecular Dynamics Simulation | 1 | 2017 | 4155 | 0.27 | Why? |
| Quinolines | 2 | 2018 | 403 | 0.27 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3832 | 0.26 | Why? |
| Prognosis | 8 | 2020 | 32490 | 0.26 | Why? |
| Imaging, Three-Dimensional | 2 | 2018 | 680 | 0.25 | Why? |
| Cell Proliferation | 4 | 2018 | 1973 | 0.24 | Why? |
| Middle Aged | 28 | 2020 | 270681 | 0.23 | Why? |
| Drugs, Chinese Herbal | 1 | 2017 | 2760 | 0.23 | Why? |
| MicroRNAs | 1 | 2015 | 1787 | 0.23 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.23 | Why? |
| Patient Selection | 1 | 2016 | 4560 | 0.22 | Why? |
| Proportional Hazards Models | 3 | 2020 | 6543 | 0.22 | Why? |
| Aged | 22 | 2020 | 215776 | 0.22 | Why? |
| Humans | 50 | 2021 | 930598 | 0.21 | Why? |
| Male | 29 | 2020 | 367725 | 0.20 | Why? |
| Thoracoscopy | 2 | 2018 | 113 | 0.20 | Why? |
| Kaplan-Meier Estimate | 4 | 2017 | 4260 | 0.20 | Why? |
| Indoles | 2 | 2018 | 1243 | 0.20 | Why? |
| Survival Rate | 4 | 2018 | 9206 | 0.19 | Why? |
| TRPC Cation Channels | 1 | 2018 | 7 | 0.19 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.19 | Why? |
| Female | 28 | 2020 | 380317 | 0.19 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 100 | 0.19 | Why? |
| Magnetic Field Therapy | 1 | 2018 | 14 | 0.19 | Why? |
| Phrenic Nerve | 1 | 2018 | 37 | 0.19 | Why? |
| Intubation, Intratracheal | 4 | 2018 | 3962 | 0.18 | Why? |
| Video-Assisted Surgery | 1 | 2018 | 43 | 0.18 | Why? |
| Glomus Tumor | 1 | 2017 | 4 | 0.18 | Why? |
| Tuberculosis, Pleural | 1 | 2017 | 22 | 0.18 | Why? |
| Thymectomy | 1 | 2017 | 26 | 0.18 | Why? |
| Apoptosis | 3 | 2018 | 2335 | 0.18 | Why? |
| Calcium Channels | 1 | 2018 | 96 | 0.18 | Why? |
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 17 | 0.18 | Why? |
| Carbazoles | 1 | 2019 | 120 | 0.18 | Why? |
| Clonal Evolution | 1 | 2017 | 55 | 0.18 | Why? |
| Lipogenesis | 1 | 2017 | 49 | 0.17 | Why? |
| Medical History Taking | 1 | 2020 | 350 | 0.17 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.17 | Why? |
| Urinary Catheterization | 1 | 2017 | 47 | 0.17 | Why? |
| Adenosine Deaminase | 1 | 2017 | 85 | 0.17 | Why? |
| Neoplasm Transplantation | 1 | 2016 | 55 | 0.16 | Why? |
| Ipilimumab | 1 | 2017 | 102 | 0.16 | Why? |
| AMP-Activated Protein Kinases | 1 | 2017 | 93 | 0.16 | Why? |
| Transplants | 1 | 2018 | 136 | 0.16 | Why? |
| RNA Editing | 1 | 2017 | 80 | 0.16 | Why? |
| China | 10 | 2020 | 50654 | 0.16 | Why? |
| Gene Rearrangement | 1 | 2016 | 84 | 0.16 | Why? |
| Postoperative Complications | 4 | 2018 | 5861 | 0.15 | Why? |
| Pulmonary Ventilation | 1 | 2017 | 152 | 0.15 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.15 | Why? |
| Exome | 1 | 2017 | 207 | 0.15 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.15 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 291 | 0.15 | Why? |
| Adult | 20 | 2020 | 244371 | 0.15 | Why? |
| Chest Tubes | 1 | 2017 | 177 | 0.15 | Why? |
| Mice, Nude | 1 | 2016 | 340 | 0.15 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Nicotine | 1 | 2018 | 213 | 0.15 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2016 | 207 | 0.15 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.14 | Why? |
| Area Under Curve | 3 | 2018 | 2564 | 0.14 | Why? |
| Cell Transformation, Neoplastic | 1 | 2016 | 191 | 0.14 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.14 | Why? |
| Fatty Acids | 1 | 2016 | 238 | 0.14 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2015 | 64 | 0.14 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.14 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| Enteral Nutrition | 1 | 2017 | 320 | 0.14 | Why? |
| Lymphatic Metastasis | 1 | 2016 | 537 | 0.14 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.14 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Rabbits | 1 | 2017 | 1171 | 0.13 | Why? |
| Neoplastic Stem Cells | 1 | 2015 | 120 | 0.13 | Why? |
| Geography | 1 | 2020 | 1801 | 0.13 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.13 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.13 | Why? |
| Young Adult | 10 | 2020 | 93724 | 0.13 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2017 | 422 | 0.13 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.13 | Why? |
| Piperidines | 1 | 2019 | 795 | 0.12 | Why? |
| Tracheotomy | 1 | 2017 | 427 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.11 | Why? |
| Myasthenia Gravis | 1 | 2017 | 385 | 0.11 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.11 | Why? |
| Carcinoma | 1 | 2015 | 256 | 0.11 | Why? |
| Pleural Effusion | 1 | 2017 | 680 | 0.11 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.11 | Why? |
| In Vitro Techniques | 1 | 2015 | 1027 | 0.11 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.11 | Why? |
| Feasibility Studies | 2 | 2017 | 3467 | 0.11 | Why? |
| Cell Survival | 1 | 2016 | 1581 | 0.11 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| ROC Curve | 3 | 2018 | 6024 | 0.10 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Ventilation | 1 | 2017 | 1145 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.10 | Why? |
| L-Lactate Dehydrogenase | 1 | 2017 | 1995 | 0.10 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.10 | Why? |
| Lung | 4 | 2020 | 31049 | 0.10 | Why? |
| DNA Methylation | 1 | 2014 | 688 | 0.10 | Why? |
| Regression Analysis | 1 | 2016 | 2484 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.09 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.09 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Immune System | 1 | 2017 | 1479 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Transcriptome | 2 | 2017 | 3466 | 0.08 | Why? |
| Mice | 2 | 2017 | 21357 | 0.08 | Why? |
| Molecular Targeted Therapy | 1 | 2016 | 1579 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.08 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| Fever | 2 | 2020 | 7795 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Precision Medicine | 1 | 2016 | 1477 | 0.08 | Why? |
| Medicine, Chinese Traditional | 1 | 2017 | 2255 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.07 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2017 | 2043 | 0.07 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.07 | Why? |
| Animals | 3 | 2017 | 78931 | 0.06 | Why? |
| Models, Statistical | 2 | 2018 | 5312 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.06 | Why? |
| Computational Biology | 2 | 2017 | 4514 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Cell Line | 2 | 2015 | 12040 | 0.06 | Why? |
| Asthma | 1 | 2021 | 4383 | 0.06 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.06 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2016 | 9537 | 0.05 | Why? |
| United States | 2 | 2017 | 46150 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Early Detection of Cancer | 1 | 2010 | 1956 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Placebo Effect | 1 | 2018 | 108 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Calcium Signaling | 1 | 2018 | 133 | 0.04 | Why? |
| Neuromuscular Agents | 1 | 2017 | 87 | 0.04 | Why? |
| Synovial Fluid | 1 | 2017 | 64 | 0.04 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Berberine | 1 | 2017 | 98 | 0.04 | Why? |
| Quinazolines | 1 | 2017 | 126 | 0.04 | Why? |
| Breast Neoplasms | 1 | 2014 | 3633 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Length of Stay | 3 | 2018 | 11042 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 11367 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.04 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.04 | Why? |
| Genetic Heterogeneity | 1 | 2014 | 77 | 0.03 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.03 | Why? |
| Thailand | 1 | 2019 | 1155 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.03 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.03 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Airway Extubation | 1 | 2017 | 403 | 0.03 | Why? |
| Breast | 1 | 2014 | 290 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.02 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.02 | Why? |
| Republic of Korea | 1 | 2019 | 5858 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2014 | 2830 | 0.02 | Why? |
| Algorithms | 2 | 2014 | 7346 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Incidence | 1 | 2010 | 25622 | 0.01 | Why? |